National Survey on GERD Patients (Adults and Children)

AstraZeneca4,400 enrolled

Overview

To describe GERD digestive expression according to ages: - children (from 0 to 23 months) and (24 months and more)- adults (from 18 to 29 years old), (from 30 to 39 years old), (from 40 to 49 years old), (from 50 to 59 years old), (more than 60 years old)

Study Type

OBSERVATIONAL

Enrollment

4,400

Conditions

GERD (Gastroesophageal Reflux Disease)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Adults : - Male or female \> or = 18 years old - With at least one GERD typical clinical sign (pyrosis and / or acid regurgitations).- Not receiving any GERD treatment within the 3 previous months. * Children :- Male or female \< 18 years old - With GERD digestive clinical signs during the consultation (receiving treatment or not)- Whose parents or legal guardian gave oral approval to the child participation in the survey. Exclusion Criteria: \-

Locations (1053)

Outcomes

Primary Outcomes

To describe GERD digestive expression according to ages: - children (from 0-23 months) and (24 months and more)- adults (from 18-29 years old), (from 30-39 years old), (from 40-49 years old), (from 50-59 years old), (more than 60 years old)

Time frame: once

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Abbaretz, France

Research Site

Abbeville, France

Research Site

Acheux-en-Amiénois, France

Research Site

Achicourt, France

Research Site

Adriers, France

Research Site

Agen, France

Research Site

Aigrefeuille-sur-Maine, France

Research Site

Aire-sur-l'Adour, France

Research Site

Aire-sur-la-Lys, France

Research Site

Airvault, France

...and 1043 more locations